pidotimod has been researched along with Nasal Catarrh in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canonica, GW; Feleszko, W; Kalyuzhin, O; Krenke, R; Rossi, GA; Van Gerven, L | 1 |
| Careddu, P; Corsini, A; Mei, V; Venturoli, V | 1 |
1 review(s) available for pidotimod and Nasal Catarrh
| Article | Year |
|---|---|
Immunoactive preparations and regulatory responses in the respiratory tract: potential for clinical application in chronic inflammatory airway diseases.
Topics: Asthma; Cell Extracts; Chronic Disease; Humans; Immunization; Immunologic Factors; Immunomodulation; Inflammation; Probiotics; Pulmonary Disease, Chronic Obstructive; Pyrrolidonecarboxylic Acid; Respiratory System; Respiratory Tract Diseases; Rhinitis; Sinusitis; Thiazolidines | 2020 |
1 trial(s) available for pidotimod and Nasal Catarrh
| Article | Year |
|---|---|
Pidotimod in the treatment of recurrent respiratory infections in paediatric patients.
Topics: Bronchitis; Child; Child, Preschool; Double-Blind Method; Female; Humans; Immunologic Factors; Laryngitis; Lymphocyte Count; Male; Otitis; Pharyngitis; Pyrrolidonecarboxylic Acid; Recurrence; Respiratory Tract Infections; Rhinitis; Thiazoles; Thiazolidines; Tracheitis | 1994 |